X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2557) 2557
Publication (349) 349
Book Review (39) 39
Magazine Article (17) 17
Newsletter (9) 9
Book Chapter (3) 3
Newspaper Article (2) 2
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2373) 2373
hiv infections - drug therapy (1777) 1777
female (1656) 1656
anti-hiv agents - therapeutic use (1515) 1515
nevirapine - therapeutic use (1391) 1391
nevirapine (1324) 1324
infectious diseases (1147) 1147
adult (1088) 1088
male (1055) 1055
index medicus (1030) 1030
hiv (880) 880
reverse transcriptase inhibitors - therapeutic use (737) 737
immunology (712) 712
pregnancy (710) 710
antiretroviral therapy (616) 616
infectious disease transmission, vertical - prevention & control (585) 585
hiv infections - virology (574) 574
hiv infections - transmission (532) 532
viral load (507) 507
virology (485) 485
hiv infections - prevention & control (478) 478
middle aged (462) 462
drug therapy, combination (461) 461
infant, newborn (456) 456
hiv-1 - drug effects (439) 439
pharmacology & pharmacy (436) 436
cd4 lymphocyte count (431) 431
treatment outcome (430) 430
zidovudine (418) 418
hiv infection (417) 417
hiv-1 (391) 391
infant (389) 389
antiviral agents (384) 384
efavirenz (382) 382
anti-hiv agents - adverse effects (377) 377
zidovudine - therapeutic use (374) 374
drug therapy (373) 373
nevirapine - adverse effects (352) 352
hiv-1 - genetics (350) 350
human immunodeficiency virus--hiv (339) 339
nevirapine - administration & dosage (334) 334
pregnancy complications, infectious - drug therapy (333) 333
anti-hiv agents - administration & dosage (331) 331
aids (330) 330
prevention (328) 328
antiretroviral therapy, highly active (316) 316
antiretroviral drugs (311) 311
lamivudine - therapeutic use (310) 310
health aspects (308) 308
research (305) 305
microbiology (295) 295
highly active antiretroviral therapy (284) 284
therapy (280) 280
risk factors (277) 277
adolescent (270) 270
lamivudine (253) 253
human-immunodeficiency-virus (242) 242
pharmacokinetics (240) 240
child (237) 237
protease inhibitors (233) 233
hiv infections - complications (231) 231
hiv infections - epidemiology (228) 228
aids/hiv (226) 226
single-dose nevirapine (223) 223
mutation (220) 220
young adult (219) 219
benzoxazines - therapeutic use (216) 216
anti-retroviral agents - therapeutic use (215) 215
cohort studies (211) 211
hiv protease inhibitors - therapeutic use (210) 210
immunodeficiency-virus type-1 (209) 209
stavudine - therapeutic use (208) 208
medicine, general & internal (204) 204
child, preschool (202) 202
infection (202) 202
drug resistance, viral (201) 201
to-child transmission (199) 199
virus diseases (199) 199
retrospective studies (196) 196
children (195) 195
human immunodeficiency virus (195) 195
hiv infections - immunology (194) 194
drug resistance (193) 193
reverse transcriptase inhibitors - adverse effects (190) 190
women (190) 190
disease transmission (189) 189
rna, viral - blood (187) 187
prospective studies (186) 186
research article (186) 186
care and treatment (182) 182
acquired immune deficiency syndrome--aids (179) 179
dosage and administration (179) 179
anti-hiv agents - pharmacology (177) 177
infants (175) 175
drug resistance, viral - genetics (173) 173
treatment failure (172) 172
anti-hiv agents - pharmacokinetics (166) 166
article (164) 164
genotype (164) 164
hiv-infected patients (157) 157
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2504) 2504
French (32) 32
German (16) 16
Spanish (15) 15
Chinese (7) 7
Russian (7) 7
Japanese (4) 4
Dutch (3) 3
Polish (2) 2
Italian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 229 - 237
Summary Background The non-nucleoside reverse transcriptase inhibitor (NNRTI), rilpivirine (TMC278; Tibotec Pharmaceuticals, County Cork, Ireland), had... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | ZIDOVUDINE | COMBINATION THERAPY | ACTIVE ANTIRETROVIRAL THERAPY | EMTRICITABINE | PROTEASE-INHIBITOR | CYSTATIN-C | CREATININE | DAILY LAMIVUDINE | NEVIRAPINE | TENOFOVIR | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Nucleotides - therapeutic use | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Nucleosides - therapeutic use | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Benzoxazines - therapeutic use | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Evaluation | Patient outcomes | Clinical trials | Dosage and administration | Drug therapy | HIV infection | Design | Antiretroviral drugs | Corporate sponsorship | Human immunodeficiency virus--HIV | Technological change | Research | Clinical medicine | Drugs | RNA-directed DNA polymerase | Exanthema | antiretroviral therapy | Lamivudine | Lipids | Nucleotides | Regression analysis | Efavirenz | CD4 antigen | nucleosides | Algorithms | Hospitals | non-nucleoside reverse transcriptase inhibitors | Abacavir | Zidovudine | Pharmaceuticals
Journal Article
Lancet, The, ISSN 0140-6736, 2011, Volume 378, Issue 9787, pp. 238 - 246
Summary Background Efavirenz with tenofovir-disoproxil-fumarate and emtricitabine is a preferred antiretroviral regimen for treatment-naive patients infected... 
Internal Medicine | LAMIVUDINE | MEDICINE, GENERAL & INTERNAL | EFFICACY | SAFETY | COMBINATION THERAPY | GUIDELINES | PROTEASE-INHIBITOR | ANTIRETROVIRAL THERAPY | NEVIRAPINE | REGIMENS | Rilpivirine | HIV Reverse Transcriptase - antagonists & inhibitors | Humans | Middle Aged | Male | Anti-HIV Agents - administration & dosage | Nitriles - administration & dosage | Tenofovir | Deoxycytidine - therapeutic use | Adenine - adverse effects | Adenine - therapeutic use | Adult | Anti-HIV Agents - therapeutic use | Deoxycytidine - adverse effects | Female | Reverse Transcriptase Inhibitors - therapeutic use | Acquired Immunodeficiency Syndrome - virology | Acquired Immunodeficiency Syndrome - ethnology | Emtricitabine | Adenine - analogs & derivatives | Benzoxazines - administration & dosage | Double-Blind Method | Drug Administration Schedule | Organophosphonates - therapeutic use | HIV-1 - drug effects | Pyrimidines - administration & dosage | Anti-HIV Agents - adverse effects | Deoxycytidine - administration & dosage | Organophosphonates - adverse effects | Benzoxazines - adverse effects | Treatment Outcome | HIV-1 - genetics | Acquired Immunodeficiency Syndrome - drug therapy | Adenine - administration & dosage | Benzoxazines - therapeutic use | Organophosphonates - administration & dosage | Pyrimidines - therapeutic use | Pyrimidines - adverse effects | Aged | Mutation | Nitriles - adverse effects | Viral Load - drug effects | Deoxycytidine - analogs & derivatives | Nitriles - therapeutic use | Dosage and administration | Efavirenz | Patient outcomes | Clinical trials | Antiretroviral drugs | Drug therapy | Human immunodeficiency virus--HIV
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2009, Volume 374, Issue 9692, pp. 796 - 806
Journal Article
by Mugyenyi, P and Walker, AS and Hakim, J and Munderi, P and Gibb, DM and Kityo, C and Reid, A and Grosskurth, H and Darbyshire, JH and Ssali, F and Bray, D and Katabira, E and Babiker, AG and Gilks, CF and Kabuye, G and Nsibambi, D and Kasirye, R and Zalwango, E and Nakazibwe, M and Kikaire, B and Nassuna, G and Massa, R and Fadhiru, K and Namyalo, M and Zalwango, A and Generous, L and Khauka, P and Rutikarayo, N and Nakahima, W and Mugisha, A and Todd, J and Levin, J and Muyingo, S and Ruberantwari, A and Kaleebu, P and Yirrell, D and Ndembi, N and Lvagoba, F and Hughes, P and Aber, M and Lara, AM and Foster, S and Amurwon, J and Wakholi, BN and Whitworth, J and Wangati, K and Amuron, B and Kajungu, D and Nakiyingi, J and Omony, W and Tumukunde, D and Otim, T and Kabanda, J and Musana, H and Akao, J and Kyomugisha, H and Byamukama, A and Sabiiti, J and Komugyena, J and Wavamunno, P and Mukiibi, S and Drasiku, A and Byaruhanga, R and Labeja, O and Katundu, P and Tugume, S and Awio, P and Namazzi, A and Bakeinyaga, GT and Katabira, H and Abaine, D and Tukamushaba, J and Anywar, W and Ojiambo, W and Angweng, E and Murungi, S and Haguma, W and Atwiine, S and Kigozi, J and Namale, L and Mukose, A and Mulindwa, G and Atwiine, D and Muhwezi, A and Nimwesiga, E and Barungi, G and Takubwa, J and Mwebesa, D and Kagina, G and Mulindwa, M and Ahimbisibwe, F and Mwesigwa, P and Akuma, S and Zawedde, C and Nyiraguhirwa, D and Tumusiime, C and Bagaya, L and Namara, W and Karungi, J and Kankunda, R and ... and DART Trail Grp and DART Trial Team
Lancet, The, ISSN 0140-6736, 2010, Volume 375, Issue 9709, pp. 123 - 131
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 06/2012, Volume 366, Issue 25, pp. 2380 - 2389
Journal Article
Journal of Infectious Diseases, ISSN 0022-1899, 04/2015, Volume 211, Issue 8, pp. 1211 - 1218
Journal Article
Journal Article
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Journal Article